‹ Back
Ara-290, Cibinetide · What it helps
Blood sugar and diabetes
In type 2 diabetes, Ara-290 improved HbA1c and lipids along with neuropathic symptoms over 28 days. It protects islet cells from inflammatory damage. Diabetic nerve damage and insulin failure share the same inflammation. It works on both at once.
Sources
Read the original sources
- ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes (Abstract · checked 2026-10-13)
- Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand. (Yao · 2020 · Abstract; full methods not assumed · checked 2026-10-13)